olutasidenib (Rezlidhia)

From Aaushi
Jump to navigation Jump to search

Indications

Dosage

Adverse effects

* boxed warning for risk of differentiation syndrome

Laboratory

  • Abbott RealTime IDH1 Assay is accompanying FDA-approved test

Mechanism of action

More general terms

References

Database